MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Gut Dysbiosis Alters Host Metabolism but Does Not Independently Induce Parkinson’s Disease Pathology

HY. Huang, TH. Yeh, SP. Tsao (Taipei, Taiwan)

Meeting: 2025 International Congress

Keywords: Dopaminergic neurons, Inflammation, Parkinson’s

Category: Parkinson's Disease (Other)

Objective: To determine whether gut dysbiosis alone is sufficient to induce Parkinson’s disease (PD) pathology and to investigate its impact on host metabolism.

Background: Gut microbiota dysbiosis has been implicated in PD progression, but its role in disease initiation remains unclear. While previous studies have shown microbial composition shifts in PD patients, the causative relationship between dysbiosis and neurodegeneration is not well established.

Method: Fecal microbiota from 18-month-old VPS35D620N/+ knockin mice, a model of PD-associated dysbiosis, were transplanted into germ-free C57BL/6J mice. Motor function was assessed via rotarod and grip strength tests, and dopaminergic neuron integrity was evaluated using tyrosine hydroxylase (TH) immunostaining in the substantia nigra pars compacta (SNpc). Microbiome composition and host metabolic changes were analyzed through 16S rRNA sequencing and targeted metabolomics.

Results: Transplantation of dysbiotic microbiota did not lead to significant reductions in TH-positive neurons or motor function impairment, indicating that gut dysbiosis alone does not induce PD-like neurodegeneration. However, microbiome analysis revealed marked alterations in microbial composition and metabolic pathways, including decreased levels of short-chain fatty acids (SCFAs) and tryptophan metabolites in serum. These changes suggest that dysbiosis contributes to a pre-inflammatory and nutrient-deficient state, potentially increasing susceptibility to neurodegenerative stressors.

Conclusion: While dysbiosis alone does not trigger PD pathology, its impact on host metabolism suggests a role as a disease-modifying factor. The observed metabolic disruptions, particularly in SCFA and tryptophan metabolism, highlight potential targets for therapeutic intervention. Future studies should explore how dysbiosis interacts with additional PD risk factors to influence disease onset and progression.

To cite this abstract in AMA style:

HY. Huang, TH. Yeh, SP. Tsao. Gut Dysbiosis Alters Host Metabolism but Does Not Independently Induce Parkinson’s Disease Pathology [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/gut-dysbiosis-alters-host-metabolism-but-does-not-independently-induce-parkinsons-disease-pathology/. Accessed November 20, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/gut-dysbiosis-alters-host-metabolism-but-does-not-independently-induce-parkinsons-disease-pathology/

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley